• Y-27632 for MSC Mechanobiology Workflows

  2026-08-13

  Use Y-27632 as a reversible ROCK inhibitor to separate cell-shape-driven mechanics from downstream fate decisions in mesenchymal stromal cells. This workflow combines geometric micropatterning, focal-adhesion imaging, actin organization, and YAP readouts for controlled cytoskeletal dynamics modulation.

• Nanozymes Target Intramacrophage Bacteria in CRC

  2026-08-13

  The reference study develops a macrophage-targeted, self-activating polymeric nanozyme that combines ferrocene chemistry with artesunate to eliminate intracellular Fusobacterium nucleatum in colorectal cancer. By reducing a bacterial driver of immunosuppression, the platform remodeled macrophage behavior and improved the response to CD47 blockade, while also suggesting useful lysosomal imaging readouts for mechanistic validation.

• TCEP Hydrochloride: Mechanism and Workflows

  2026-08-12

  Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a water-soluble, thiol-free reagent for disulfide bond reduction. Its documented uses include protein digestion enhancement, hydrogen-deuterium exchange analysis, reduction of dehydroascorbic acid, and selected organic synthesis workflows.

• Mouse Tissue Lysis Kit K1038: Workflow Guide

  2026-08-12

  The Mouse Tissue Lysis Kit (K1038) supports rapid digestion of mouse tail, toe, and ear tissues for direct PCR-based genotyping and DNA analysis. It is intended for molecular biology research and direct template preparation, not diagnostic, clinical, or medical use.

• WEHI-539: Practical BCL-XL Inhibitor Workflows

  2026-08-11

  WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader mitochondrial apoptosis effects. This guide converts its biochemical potency and BAK-dependent mechanism into practical workflows for apoptosis assays, glioblastoma combination studies, and cancer stem cell sensitization.

• Nebivolol hydrochloride for β1 Signaling Assays

  2026-08-11

  Build cleaner β1-adrenergic receptor experiments with Nebivolol hydrochloride, a potent β1-adrenoceptor antagonist suited to concentration-response, pathway, and selectivity studies. The compound also provides a useful negative comparator when a drug-sensitized yeast platform is used to test TOR or mTOR-related activity.

• Hexa His Tag Peptide: From Elution to Translation

  2026-08-10

  Competitive elution is more than a recovery step: it can determine whether a protein interaction dataset reflects native biology or purification artifacts. This thought-leadership article connects the mechanism of the Hexa His tag peptide with assay design, translational reproducibility, and lessons from recent CARMIL research on state-dependent protein regulation.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-09

  Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins during SDS-PAGE. This guide translates the reagent into practical workflows for kinase assays, checkpoint biology, and protein phosphorylation signaling, with controls and troubleshooting steps for reproducible mobility-shift analysis.

• Machine Learning Discovery of New Senolytics

  2026-08-08

  The reference study shows that cost-effective machine-learning models trained only on published screening data can identify senolytic candidates from chemical libraries. Its validation of ginkgetin, periplocin, and oleandrin illustrates how computational prioritization can reduce early drug-discovery costs while exposing important questions about cell-type selectivity, mechanism, and translational safety.

• GW 4869: Exosome Workflow for Osteogenesis

  2026-08-07

  GW 4869 helps separate exosome-dependent osteogenic signaling from direct effects on bone mesenchymal stem cells. This practical workflow uses neutral sphingomyelinase inhibition to test lithium-engineered exosome release, Wnt10a cargo delivery, and downstream β-catenin activation with tighter controls.

• Cy3-UTP: Advancing In Vitro RNA Labeling for Trafficking Stu

  2026-08-07

  Cy3-UTP from APExBIO transforms in vitro transcription workflows by enabling robust, photostable fluorescent RNA labeling. Its high incorporation efficiency and spectral brightness empower researchers to dissect RNA trafficking and nanoparticle delivery with quantitative precision, overcoming key limitations in live-cell imaging and RNA-protein interaction studies.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition in Alzhei

  2026-08-06

  Lanabecestat (AZD3293) offers unprecedented precision in amyloid-beta pathway modulation for Alzheimer’s disease research. This article synthesizes mechanistic insight, translational strategy, and the latest evidence—including pivotal synaptic-sparing data—to guide researchers in leveraging BACE1 inhibition for maximal scientific and clinical relevance. By integrating workflow guidance and benchmarking Lanabecestat’s unique properties, we deliver actionable recommendations for next-generation translational studies.

• Foretinib (GSK1363089): Precision Inhibition of Tumor Progre

  2026-08-06

  Explore Foretinib (GSK1363089) as a precision multikinase inhibitor for advanced cancer research. This article uniquely dissects the dual impact on tumor proliferation and cell viability, with deep insight from recent in vitro drug response advances.

• Okadaic Acid: Protocol Parameters and Best Practices (A4540)

  2026-08-05

  Okadaic acid is a high-potency protein phosphatase 1 inhibitor, essential for dissecting phosphorylation-dependent signaling and apoptosis in cell biology and biochemical research. It is best suited for controlled studies of PP1 and PP2A inhibition but should be avoided in workflows requiring non-overlapping phosphatase specificity or minimal solvent sensitivity.

• Selective Autophagy Regulates IRF3 Stability and Immune Bala

  2026-08-05

  Wu et al. (2021) reveal that selective autophagy, via CALCOCO2/NDP52-mediated targeting and PSMD14/POH1 deubiquitination, finely tunes the stability of transcription factor IRF3 to control type I interferon production and immune suppression during viral infection. This mechanistic insight advances our understanding of autophagy’s role in antiviral immunity and transcription factor regulation.

7718 records 3/515 page Previous Next 12345 下5页 Last page